Clinical Trial

Ustekinumab Real World Evidence Study

Study acronym: UndieS
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to capture the real-world experience of CD patients treated with ustekinumab as part of their clinical care in a variety of care settings from large teaching/research centres to smaller district hospitals.
Trial Details
NCT Number NCT07748338
Lead Sponsor University Hospital Southampton NHS Foundation Trust
Collaborators: Liverpool University Hospitals NHS Foundation Trust
Conditions Crohn's Disease
Enrollment 601 participants
Start Date 2019-10-30
Primary Completion 2025-03-20 (estimated)
Study Completion 2025-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-08-05